Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, “Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Obsessive Compulsive Disorder Therapeutics market. The report identifies the key trends shaping and driving the global Obsessive Compulsive Disorder Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Obsessive Compulsive Disorder Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Obsessive Compulsive Disorder Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Obsessive Compulsive Disorder Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Obsessive-Compulsive Disorder Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Obsessive Compulsive Disorder Therapeutics market

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Obsessive Compulsive Disorder Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Obsessive Compulsive Disorder Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Obsessive Compulsive Disorder Therapeutics market landscape? – Identify, understand and capitalize. SHOW LESS READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Obsessive Compulsive Disorder Therapeutics - Introduction
2.1 Disease Overview
2.1.1 Mild Obsessive Compulsive Disorder
2.1.2 Moderate Obsessive Compulsive Disorder
2.1.3 Severe Obsessive Compulsive Disorder
2.2 Epidemiology
2.2.1 Prevalence
2.2.2 Quality of Life Parameters
2.3 Etiology and Pathophysiology
2.3.1 Seretonin Hypothesis
2.3.2 Dopamine Hypothesis
2.3.3 Genetics
2.3.4 Autoimmune
2.4 Obsessive Compulsive Disorder Signs and Symptoms
2.4.1 Obsessive Thoughts
2.4.2 Compulsive Behaviors
2.5 Diagnosis
2.5.1 Diagnostic Criteria for Obsessive Compulsive Disorder Defined by DSM-IV
2.5.2 Measurement Scales
2.6 Treatment and Management Options
2.6.1 Psychological Treatment
2.6.2 Pharmacologic Treatment
2.6.3 Combination Treatment
2.7 Referral Pathway
2.8 GlobalData Pipeline Report Guidance
3 Obsessive Compulsive Disorder Therapeutics - Market Characterization
3.1 Overview
3.2 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – Global
3.3 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) - Global
3.4 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – The US
3.5 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) – The US
3.6 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – France
3.7 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) – France
3.8 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – Germany
3.9 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) – Germany
3.10 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – Italy
3.11 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) – Italy
3.12 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – Spain
3.13 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) – Spain
3.14 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – The UK
3.15 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) – The UK
3.16 Obsessive Compulsive Disorder Therapeutics Market Size (2006-2011) – Japan
3.17 Obsessive Compulsive Disorder Therapeutics Market Forecast (2011-2019) – Japan
3.18 Drivers and Barriers for the Obsessive Compulsive Disorder Therapeutics Market
3.18.1 Drivers for the Obsessive Compulsive Disorder Therapeutics Market
3.18.2 Barriers for the Obsessive Compulsive Disorder Therapeutics Market
3.19 Opportunity and Unmet Need Analysis
3.20 Key Takeaway
4 Obsessive Compulsive Disorder Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Marketed Products in the Obsessive Compulsive Disorder Therapeutics Market
4.3.1 Paroxetine hydrochloride
4.3.2 Sertraline hydrochloride
4.3.3 Fluvoxamine maleate
4.3.4 Fluoxetine hydrochloride
4.3.5 Clomipramine hydrochloride
4.4 Key Takeaway
5 Obsessive Compulsive Disorder Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Obsessive Compulsive Disorder Therapeutics Pipeline – Pipeline by Phases of Development
5.3.1 Obsessive Compulsive Disorder Therapeutics – Phase III Pipeline
5.3.2 Obsessive Compulsive Disorder Therapeutics – Phase II Pipeline
5.3.3 Obsessive Compulsive Disorder Therapeutics – Pre-Clinical Pipeline
5.3.4 Obsessive Compulsive Disorder Therapeutics –Discovery Pipeline
5.3.5 Technology Trends Analytic Framework
5.4 Obsessive Compulsive Disorder Therapeutics Market –Pipeline by Mechanism of Action
5.5 Molecule Profile for Promising Drugs under Clinical Development
5.5.1 Gamunex
5.5.2 TO-2061 (ondansetron)
5.6 Key Takeaway
6 Obsessive Compulsive Disorder Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Top Companies Participating in Obsessive Compulsive Disorder Therapeutics Clinical Trials
7 Obsessive Compulsive Disorder Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Obsessive Compulsive Disorder Therapeutics: Implications for Future Market Competition
8 Obsessive Compulsive Disorder Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Transcept Pharmaceuticals, Inc.
9 OCD Therapeutics - Appendix
9.1 Market Definitions
9.2 Abbreviations
9.3 Research Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Forecasting
9.3.4 Primary Research
9.3.5 Expert Panel Validation
9.4 Contact Us
9.5 Disclaimer
9.6 Bibliography

1.1 List of Tables
Table 1: Prevalent Pool of Obsessive Compulsive Disorder in Seven Major Markets
Table 2: Obsessive Compulsive Disorder Therapeutics Market, Global, Revenue ($m), 2006–2011
Table 3: Obsessive Compulsive Disorder Therapeutics Market, Global, Forecast ($m), 2011–2019
Table 4: Obsessive Compulsive Disorder Therapeutics Market, The US, Revenue ($m), 2006–2011
Table 5: Obsessive Compulsive Disorder Therapeutics Market, The US, Forecasts ($m), 2011–2019
Table 6: Obsessive Compulsive Disorder Therapeutics Market, France, Revenue ($m), 2006–2011
Table 7: Obsessive Compulsive Disorder Therapeutics Market, France, Forecasts ($m), 2011–2019
Table 8: Obsessive Compulsive Disorder Therapeutics Market, Germany, Revenue ($m), 2006–2011
Table 9: Obsessive Compulsive Disorder Therapeutics Market, Germany, Forecasts ($m), 2011–2019
Table 10: Obsessive Compulsive Disorder Therapeutics Market, Italy, Revenue ($m), 2006–2011
Table 11: Obsessive Compulsive Disorder Therapeutics Market, Italy, Forecasts ($m), 2011–2019
Table 12: Obsessive Compulsive Disorder Therapeutics Market, Spain, Revenue ($m), 2006–2011
Table 13: Obsessive Compulsive Disorder Therapeutics Market, Spain, Forecasts ($m), 2011–2019
Table 14: Obsessive Compulsive Disorder Therapeutics Market, The UK, Revenue ($m), 2006–2011
Table 15: Obsessive Compulsive Disorder Therapeutics Market, The UK, Forecasts ($m), 2011–2019
Table 16: Obsessive Compulsive Disorder Therapeutics Market, Japan, Revenue ($m), 2006–2011
Table 17: Obsessive Compulsive Disorder Therapeutics Market, Japan, Forecasts ($m), 2011–2019
Table 18: Outcome Classification (%) on CGI Global Improvement Item for Study 1
Table 19: Outcome Classification (%) on CGI-Global Improvement Item for Completers in Pool of Two Adult Obsessive Compulsive Disorder Studies
Table 20: Outcome Classification (%) on CGI Global Improvement Item for Two Obsessive Compulsive Disorder Studies
Table 21: Obsessive Compulsive Disorder Therapeutics – Phase III Pipeline, 2012
Table 22: Obsessive Compulsive Disorder Therapeutics – Phase II Pipeline, 2012
Table 23: Obsessive Compulsive Disorder Therapeutics – Pre-Clinical Pipeline, 2012
Table 24: Obsessive Compulsive Disorder Therapeutics – Discovery Pipeline, 2012
Table 25: Obsessive Compulsive Disorder Therapeutics – Clinical Trials by Country, 2012
Table 26: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Phase, 2012
Table 27: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Status, 2012
Table 28: Obsessive Compulsive Disorder Therapeutics - Prominent Sponsors, 2012
Table 29: Obsessive Compulsive Disorder Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2012
Table 30: Transcept Pharmaceuticals –Pipeline for OCD, 2012

1.2 List of Figures
Figure 1: Key Opinion Leader Insights, Prevalence of Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 2: Orbito-Subcortical Circuits Pathway Associated with Obsessive Compulsive Disorder
Figure 3: Key Opinion Leader Insights, Diagnosis of Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 4: Key Opinion Leader Insights, Guidelines for Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 5: Key Opinion Leader Insights, Treatment of Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 6: Key Opinion Leader Insights, Pharmacological Treatment for Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 7: Referral Pathway for Obsessive Compulsive Disorder
Figure 8: Key Opinion Leader Insights, Referral Pathway for Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 9: Obsessive Compulsive Disorder Therapeutics Market, Global, Revenue ($m), 2006–2011
Figure 10: Obsessive Compulsive Disorder Therapeutics Market, Global, Forecast ($m), 2011–2019
Figure 11: Obsessive Compulsive Disorder Therapeutics Market, the US, Revenue ($m), 2006–2011
Figure 12: Obsessive Compulsive Disorder Therapeutics Market, The US, Forecast ($m), 2011–2019
Figure 13: Obsessive Compulsive Disorder Therapeutics Market, France, Revenue ($m), 2006–2011
Figure 14: Obsessive Compulsive Disorder Therapeutics Market, France, Forecast ($m), 2011–2019
Figure 15: Obsessive Compulsive Disorder Therapeutics Market, Germany , Revenue ($m), 2006–2011
Figure 16: Obsessive Compulsive Disorder Therapeutics Market, Germany , Forecast ($m), 2011–2019
Figure 17: Obsessive Compulsive Disorder Therapeutics Market, Italy, Revenue ($m), 2006–2011
Figure 18: Obsessive Compulsive Disorder Therapeutics Market, Italy, Forecast ($m), 2011–2019
Figure 19: Obsessive Compulsive Disorder Therapeutics Market, Spain, Revenue ($m), 2006–2011
Figure 20: Obsessive Compulsive Disorder Therapeutics Market, Spain, Forecast ($m), 2011–2019
Figure 21: Obsessive Compulsive Disorder Therapeutics Market, The UK, Revenue ($m), 2006–2011
Figure 22: Obsessive Compulsive Disorder Therapeutics Market, The UK, Forecast ($m), 2011–2019
Figure 23: Obsessive Compulsive Disorder Therapeutics Market, Japan, Revenue ($m), 2006–2011
Figure 24: Obsessive Compulsive Disorder Therapeutics Market, Japan, Forecast ($m), 2011–2019
Figure 25: Key Opinion Leader Insights, Current Unmet Need for Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 26: Opportunity and Unmet Need in the Obsessive Compulsive Disorder Therapeutics Market
Figure 27: Key Opinion Leader Insights, Limitations with the Currently Available Treatment Options for Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 28: Obsessive Compulsive Disorder Therapeutics – Strategic Competitor Assessment, 2011
Figure 29: Key Opinion Leader Insights, Research for Future Treatment Options for Obsessive Compulsive Disorder in the US, Germany and Japan
Figure 30: Obsessive Compulsive Disorder Therapeutics – Pipeline by Phase of Development, 2012
Figure 31: Obsessive Compulsive Disorder Therapeutics – Technology Trends Analytics Framework, 2012
Figure 32: Obsessive Compulsive Disorder Therapeutics – Technology Trends Analytics Framework – Description, 2012
Figure 33: Obsessive Compulsive Disorder Therapeutics – Pipeline by Mechanism of Action, 2012
Figure 34: Clinical Trial Details of Gammunex
Figure 35: Clinical Trial Details of TO-2061 (ondansetron)
Figure 36: Obsessive Compulsive Disorder Therapeutics – Clinical Trials by Country, 2012
Figure 37: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Phase, 2012
Figure 38: Obsessive Compulsive Disorder Therapeutics - Clinical Trials by Status, 2012
Figure 39: Obsessive Compulsive Disorder Therapeutics - Overall Sponsors, 2012
Figure 40: Obsessive Compulsive Disorder Therapeutics - Prominent Sponsors, 2012
Figure 41: Obsessive Compulsive Disorder Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2012
Figure 42: Obsessive Compulsive Disorder Therapeutics Market, Drivers and Restraints 2011
Figure 43: Implications for Future Market Competition in the Obsessive Compulsive Disorder Market, 2011
Figure 44: Obsessive Compulsive Disorder Therapeutics Market – Pipeline by Company, 2012

Transcept Pharmaceuticals, Inc